From Clot Prevention to Kidney Injury: Revisiting Anticoagulant-Related Nephropathy
ARN is an increasingly recognized cause of AKI in anticoagulated patients, particularly those with CKD. The condition is often associated with incomplete or absent renal recovery and significantly higher mortality in non-recovering patients. Therefore, early recognition and appropriate risk stratification are crucial, although current treatment options remain largely supportive. Further research is needed to establish validated diagnostic criteria and effective therapeutic strategies.
Authors
- Sandra Karanović
- Nasim Wiegley
- Tiffany Caza
- Sayna Norouzi (ORCID: https://orcid.org/0000-0001-9912-4959)
- Irene Martín Capón
- Paolo Nikolai So
- Mohamed Hassanein
- Harish Seethapathy
- Paul E. Hanna
- Edgar Lerma
Institutions
- Piedmont Athens Regional (US)
- Harvard University (US)
- University of Zagreb (HR)
- Medical College of Wisconsin (US)
- Loma Linda University (US)
- University of Illinois Chicago (US)
- University of Chicago (US)
- Research Institute Hospital 12 de Octubre (ES)
- Arkana Laboratories (US)
- Kidney Associates (US)
- University of California, Davis (US)
Publication Details
- Journal
- Kidney & Blood Pressure Research
- Published
- 2026-01-26
- DOI
- https://doi.org/10.1159/000550599
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00